LogicBio Therapeutics Inc
F:0IF
Income Statement
Earnings Waterfall
LogicBio Therapeutics Inc
Income Statement
LogicBio Therapeutics Inc
| Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
|
| Revenue |
5
N/A
|
7
+48%
|
11
+50%
|
12
+8%
|
12
+6%
|
13
+6%
|
13
-5%
|
13
+4%
|
14
+6%
|
15
+7%
|
17
+13%
|
18
+8%
|
18
-3%
|
18
+1%
|
16
-8%
|
14
-13%
|
14
-5%
|
12
-12%
|
11
-10%
|
10
-9%
|
7
-30%
|
12
+72%
|
15
+28%
|
17
+11%
|
21
+24%
|
15
-29%
|
10
-28%
|
71
+578%
|
|
| Gross Profit | |||||||||||||||||||||||||||||
| Cost of Revenue |
(2)
|
(4)
|
(5)
|
(5)
|
(5)
|
(6)
|
(6)
|
(7)
|
(6)
|
(6)
|
(7)
|
(7)
|
(7)
|
(8)
|
(7)
|
(6)
|
(5)
|
(5)
|
(5)
|
(4)
|
(3)
|
(7)
|
(10)
|
(13)
|
(16)
|
(13)
|
(11)
|
(36)
|
|
| Gross Profit |
2
N/A
|
4
+47%
|
6
+70%
|
7
+9%
|
7
+6%
|
8
+7%
|
6
-17%
|
7
+3%
|
8
+16%
|
8
+12%
|
10
+21%
|
11
+12%
|
10
-11%
|
10
+2%
|
10
-7%
|
8
-16%
|
8
+2%
|
7
-14%
|
6
-14%
|
6
-8%
|
3
-39%
|
5
+32%
|
5
+9%
|
4
-21%
|
5
+21%
|
2
-67%
|
(0)
N/A
|
35
N/A
|
|
| Operating Income | |||||||||||||||||||||||||||||
| Operating Expenses |
(7)
|
(10)
|
(19)
|
(20)
|
(22)
|
(26)
|
(24)
|
(26)
|
(26)
|
(32)
|
(36)
|
(28)
|
(29)
|
(30)
|
(28)
|
(27)
|
(24)
|
(21)
|
(17)
|
(14)
|
(10)
|
(13)
|
(17)
|
(20)
|
(24)
|
(23)
|
(18)
|
(36)
|
|
| Selling, General & Administrative |
(5)
|
(7)
|
(13)
|
(22)
|
(24)
|
(27)
|
(19)
|
(20)
|
(19)
|
(17)
|
(18)
|
(18)
|
(18)
|
(18)
|
(17)
|
(15)
|
(14)
|
(13)
|
(10)
|
(9)
|
(8)
|
(8)
|
(10)
|
(11)
|
(13)
|
(14)
|
(12)
|
(17)
|
|
| Research & Development |
(2)
|
(3)
|
(6)
|
(5)
|
(6)
|
(6)
|
(3)
|
(5)
|
(5)
|
(5)
|
(6)
|
(6)
|
(6)
|
(6)
|
(6)
|
(5)
|
(5)
|
(4)
|
(3)
|
(3)
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
(0)
|
0
|
0
|
(1)
|
(2)
|
(3)
|
(4)
|
(4)
|
(4)
|
(5)
|
(6)
|
(6)
|
(6)
|
(6)
|
(4)
|
(3)
|
(2)
|
(0)
|
(3)
|
(6)
|
(9)
|
(11)
|
(9)
|
(6)
|
(19)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
7
|
7
|
7
|
0
|
0
|
0
|
(6)
|
(7)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(4)
N/A
|
(7)
-60%
|
(13)
-88%
|
(13)
-5%
|
(15)
-15%
|
(18)
-20%
|
(17)
+5%
|
(20)
-15%
|
(19)
+5%
|
(24)
-26%
|
(25)
-7%
|
(17)
+34%
|
(19)
-13%
|
(20)
-5%
|
(19)
+5%
|
(19)
+0%
|
(16)
+14%
|
(14)
+13%
|
(11)
+24%
|
(9)
+19%
|
(7)
+20%
|
(8)
-19%
|
(12)
-46%
|
(16)
-31%
|
(19)
-23%
|
(21)
-11%
|
(18)
+15%
|
(0)
+99%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||||||
| Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
(1)
|
(2)
|
(2)
|
(3)
|
(1)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
2
|
3
|
3
|
(1)
|
7
|
5
|
(2)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(7)
|
0
|
0
|
(5)
|
(12)
|
(28)
|
(43)
|
(45)
|
(39)
|
(24)
|
(8)
|
(9)
|
0
|
0
|
(0)
|
0
|
(0)
|
(2)
|
(4)
|
(4)
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
(0)
|
(0)
|
1
|
1
|
1
|
(1)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(2)
|
(3)
|
(2)
|
(2)
|
(1)
|
(1)
|
(11)
|
(10)
|
(10)
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(4)
N/A
|
(7)
-61%
|
(12)
-88%
|
(13)
-5%
|
(15)
-15%
|
(18)
-20%
|
(16)
+9%
|
(18)
-12%
|
(26)
-43%
|
(27)
-4%
|
(29)
-9%
|
(26)
+11%
|
(33)
-27%
|
(48)
-45%
|
(63)
-30%
|
(66)
-6%
|
(59)
+11%
|
(41)
+32%
|
(23)
+44%
|
(20)
+11%
|
(9)
+57%
|
(18)
-107%
|
(19)
-6%
|
(22)
-18%
|
(21)
+4%
|
(16)
+26%
|
(17)
-8%
|
(6)
+65%
|
|
| Net Income | |||||||||||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
2
|
2
|
3
|
3
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
|
| Income from Continuing Operations |
(4)
|
(7)
|
(12)
|
(13)
|
(15)
|
(18)
|
(16)
|
(18)
|
(26)
|
(27)
|
(30)
|
(26)
|
(31)
|
(46)
|
(60)
|
(64)
|
(59)
|
(40)
|
(22)
|
(20)
|
(9)
|
(18)
|
(19)
|
(22)
|
(21)
|
(16)
|
(17)
|
(8)
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Equity Earnings Affiliates |
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Income (Common) |
(4)
N/A
|
(7)
-61%
|
(12)
-88%
|
(13)
-5%
|
(15)
-15%
|
(18)
-19%
|
(16)
+13%
|
(17)
-12%
|
(25)
-45%
|
(26)
-4%
|
(30)
-12%
|
(26)
+11%
|
(31)
-19%
|
(47)
-49%
|
(70)
-50%
|
(71)
-1%
|
(80)
-13%
|
(61)
+24%
|
(34)
+44%
|
(34)
-1%
|
(12)
+66%
|
(21)
-80%
|
(22)
-5%
|
(25)
-15%
|
(21)
+16%
|
(16)
+26%
|
(17)
-8%
|
(8)
+55%
|
|
| EPS (Diluted) |
-1 099.48
N/A
|
-2 186.11
-99%
|
-4 106.95
-88%
|
-479.18
+88%
|
-2 733.21
-470%
|
-2 863.06
-5%
|
-517.8
+82%
|
-495.17
+4%
|
-2 296.47
-364%
|
-475.96
+79%
|
-481.57
-1%
|
-398.36
+17%
|
-2 443.75
-513%
|
-592.7
+76%
|
-792.38
-34%
|
-365.78
+54%
|
-2 732.68
-647%
|
-226.12
+92%
|
-71.93
+68%
|
-83.28
-16%
|
-3 120.75
-3 647%
|
-0.64
+100%
|
-0.56
+12%
|
-0.62
-11%
|
-2.54
-310%
|
-0.22
+91%
|
-1.12
-409%
|
0
N/A
|
|